HbO2 Therapeutics
PrivateLast Round
IPO
Apr 26, 2022
Total Funding Raised
$6.59M
Company Overview
HbO2 Therapeutics is a biotechnology company that develops, manufactures, and commercializes a proprietary technology platform for oxygen-carrying solutions for human and veterinary medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HbO2 Therapeutics Comparables
Compare HbO2 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VirTech Bio | 86% | |
| OxyVita Inc. | 86% | |
| Prolong Pharmaceuticals, LLC | 84% | |
HbO2 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Apr 26, 2022 | ||||
| Convertible Debt | Dec 31, 2021 | ||||
| Early Funding | Mar 13, 2015 |
HbO2 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WestPark Capital, Inc. | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
Monthly visitors increased 41% MoM.
- May 1, 2025
Monthly visitors grew 118% MoM, reaching 2K.
HbO2 Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HbO2 Therapeutics's valuation, stock price, and market status.